Diligence Obligation. Latigo, acting itself and/or through its Affiliates or Sublicensees, shall use Commercially Reasonable Efforts to (a) develop (including filing for Regulatory Approval for) a Licensed Product for the Field in the Territory and (b) commercialize such Licensed Product in each jurisdiction in which Regulatory Approval is obtained. As between the Parties, Latigo shall conduct all development and commercialization-related activities in connection with the Licensed Program transferred hereunder, at Latigo’s sole expense.
Appears in 2 contracts
Sources: License Agreement (Latigo Biotherapeutics, Inc.), License Agreement (Latigo Biotherapeutics, Inc.)